SCORED and SOLOIST trials add to evidence for treating diabetes with SGLT2 inhibitors

(Brigham and Women's Hospital) In these two paired trials, teams of investigators led by Brigham cardiologist Deepak L. Bhatt, MD, MPH, evaluated sotagliflozin, a drug that inhibits SGLT2 and SGLT1. Results of the trials are both published in The New England Journal of Medicine and presented by Bhatt simultaneously at the Late-Breaking Clinical Trial Sessions of the American Heart Association Scientific Sessions.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news